SERA PROGNOSTICS, INC. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
SERA PROGNOSTICS, INC. (SERA) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $229.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-08-12
- 2026-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $229.00K.
- 2026-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $306.00K.
- 2025-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $385.00K.
- 2025-09-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $463.00K.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2026-06-30 | $229.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $306.00K 10-Q · filed 2026-05-06 |
| 2025-12-31 | $385.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $463.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $542.00K 10-Q · filed 2025-08-06 |
| 2025-03-31 | $620.00K 10-Q · filed 2025-05-07 |
| 2024-12-31 | $699.00K 10-K · filed 2026-03-18 |
| 2024-09-30 | $777.00K 10-Q · filed 2024-11-06 |
| 2024-06-30 | $855.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $934.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $1.01M 10-K · filed 2025-03-19 |
| 2023-09-30 | $1.09M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.17M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $1.23M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $1.32M 10-K · filed 2024-03-20 |
| 2022-09-30 | $1.40M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.48M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $1.19M 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |